Advanced search
Publication Cover
Vascular Health and Risk Management Volume 3, 2007 - Issue 6
Submit an article Journal homepage
48
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Secular trends in lipid-lowering treatment and lipid levels after a first acute myocardial infarction

Lena Björck1 Department of medicine, Sahlgrenska University Hospital/ÖstraGöteborg, SwedenCorrespondence[email protected]
,
Catharina Welin2 Institute of Health and Care Sciences, the Sahlgrenska Academy at Göteborg UniversityGöteborg, Sweden
&
Annika Rosengren1 Department of medicine, Sahlgrenska University Hospital/ÖstraGöteborg, Sweden
Pages 1045-1051 | Published online: 28 Dec 2022

References

  • Clofibrate and niacin in coronary heart diseaseJAMA1975231360811088963
  • W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal InvestigatorsLancet19802379856105515
  • The Lipid Research Clinics Coronary Primary Prevention Trial results. Reduction in incidence of coronary heart diseaseJAMA1984a25135164
  • The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol loweringJAMA1984b25136574
  • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)Lancet1994344138397968073
  • Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey ProgrammeEur Heart J2001225547211259143
  • AbildstromSZRasmussenSRosenMTrends in incidence and case fatality rates of acute myocardial infarction in Denmark and SwedenHeart2003895071112695453
  • BeckerWPearsonMRiksmaten 1997–98, kostvanor och näringsintag i Sverige, metod-och resultatrapport (Dierary habits and nutrient intake in Sweden 1997–98)2002UppsalaInformation and Nutrition Department, Swedish National Food Administration
  • BergCMLissnerLAiresNTrends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICAEur J Cardiovasc Prev Rehab20051211525
  • BlankenhornDHNessimSAJohnsonRLBeneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass graftsJAMA19872573233403295315
  • BrensikeJFLevyRIKelseySFEffects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention StudyCirculation198469313246360414
  • BuchwaldHVarcoRLMattsJPEffect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)N Engl J Med1990323946552205799
  • De BackerGAmbrosioniEBorch-JohnsenEuropean guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical PracticeEur Heart J20032416011012964575
  • EvansATolonenHHenseHWTrends in coronary risk factors in the WHO MONICA projectInt J Epidemiol200130Suppl 1354011171847
  • [HPSCG] Heart Protection Collaborative GroupMRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trialLancet200236072212114036
  • LawMRWaldNJAn ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990Eur J Clin Nutr199448305258055847
  • LawMRWaldNJThompsonSGBy how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?BMJ1994a308367728043072
  • LawMRWaldNJWuTSystematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA studyBMJ1994b30836368124143
  • LevyRIBrensikeJFEpsteinSEThe influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention StudyCirculation198469325376360415
  • PekkanenJLinnSHeissGTen-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular diseaseN Engl J Med1990322170072342536
  • SharrettARBallantyneCMCoadySACoronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) StudyCirculation200110411081311535564
  • ShekelleRBShyrockAMPaulODiet, serum cholesterol, and death from coronary heart disease. The Western Electric studyN Engl J Med198130465707442730
  • WattsGFLewisBBruntJNLewisESEffects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas’ Atherosclerosis Regression Study (STARS)Lancet199233956391347091
  • WilhelmsenLJohanssonSRosengrenARisk factors for cardiovascular disease during the period 1985–1995 in Goteborg, Sweden. The GOT-MONICA ProjectJ Intern Med19972421992119350164

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.